INVO Fertility (IVF) Accounts Payables (2010 - 2026)

INVO Fertility (IVF) has 17 years of Accounts Payables data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Accounts Payables fell 65.14% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $1.7 million, a 65.14% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 34.67% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.7 million, down from $2.0 million in the prior quarter.
• Over the last five years, Accounts Payables for IVF reached as high as $4.8 million in Q1 2025 and fell as low as $462211.0 in Q1 2022.
• Historically, Accounts Payables has averaged $2.1 million across 5 years, with a median of $2.0 million in 2025.
• Across the five-year window, Accounts Payables soared 299.65% in 2023 and tumbled 65.14% in 2026, its largest moves.
• Year by year, Accounts Payables stood at $1.3 million in 2022, then surged by 72.74% to $2.3 million in 2023, then soared by 33.61% to $3.1 million in 2024, then slumped by 34.67% to $2.0 million in 2025, then dropped by 17.99% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $1.7 million in Q1 2026, $2.0 million in Q4 2025, and $2.4 million in Q3 2025.